222 related articles for article (PubMed ID: 25575940)
1. Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: a pooled analysis.
Papi A; Price D; Sastre J; Kaiser K; Lomax M; McIver T; Dissanayake S
Respir Med; 2015 Feb; 109(2):208-17. PubMed ID: 25575940
[TBL] [Abstract][Full Text] [Related]
2. Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial.
Pertseva T; Dissanayake S; Kaiser K
Curr Med Res Opin; 2013 Oct; 29(10):1357-69. PubMed ID: 23865726
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial.
Płoszczuk A; Bosheva M; Spooner K; McIver T; Dissanayake S
Ther Adv Respir Dis; 2018; 12():1753466618777924. PubMed ID: 29857783
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma.
Corren J; Mansfield LE; Pertseva T; Blahzko V; Kaiser K
Respir Med; 2013 Feb; 107(2):180-95. PubMed ID: 23273405
[TBL] [Abstract][Full Text] [Related]
5. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma.
Pearlman DS; LaForce CF; Kaiser K
Clin Ther; 2013 Jul; 35(7):950-66. PubMed ID: 23870606
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial.
Nathan RA; D'Urzo A; Blazhko V; Kaiser K
BMC Pulm Med; 2012 Oct; 12():67. PubMed ID: 23078148
[TBL] [Abstract][Full Text] [Related]
7. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
[TBL] [Abstract][Full Text] [Related]
8. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study.
Aalbers R; Brusselle G; McIver T; Grothe B; Bodzenta-Lukaszyk A
Adv Ther; 2012 Nov; 29(11):958-69. PubMed ID: 23081745
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
Balki A; Balamurugan S; Bardapurkar S; Dalal S; Singh A; Singh BP; Vaidya A; Gogtay JA
Pulm Pharmacol Ther; 2018 Feb; 48():28-36. PubMed ID: 28890299
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial.
Bodzenta-Lukaszyk A; van Noord J; Schröder-Babo W; McAulay K; McIver T
Curr Med Res Opin; 2013 May; 29(5):579-88. PubMed ID: 23368897
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler.
Bodzenta-Lukaszyk A; Pulka G; Dymek A; Bumbacea D; McIver T; Schwab B; Mansikka H
Respir Med; 2011 May; 105(5):674-82. PubMed ID: 21196104
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI.
Murphy KR; Dhand R; Trudo F; Uryniak T; Aggarwal A; Eckerwall G
Respir Med; 2015 Feb; 109(2):170-9. PubMed ID: 25596138
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthma.
Dissanayake S; Jain M; Grothe B; McIver T; Papi A
Pulm Pharmacol Ther; 2015 Dec; 35():19-27. PubMed ID: 26474679
[TBL] [Abstract][Full Text] [Related]
14. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy of fluticasone/formoterol combination therapy in asthma.
Mansur AH; Kaiser K
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):190-9. PubMed ID: 23098325
[TBL] [Abstract][Full Text] [Related]
16. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
18. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
19. A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma.
Emeryk A; Klink R; McIver T; Dalvi P
Ther Adv Respir Dis; 2016 Aug; 10(4):324-37. PubMed ID: 27185164
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.
Kappeler D; Sommerer K; Kietzig C; Huber B; Woodward J; Lomax M; Dalvi P
Respir Med; 2018 May; 138():107-114. PubMed ID: 29724381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
